Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features.
Researchers investigated the potential of Ligustilide (LIG) in treating autism-like symptoms. LIG, extracted from herbs, may be effective in neurological disorders, but its impact on autism remains unknown. This study explores its therapeutic potential for ASD.
- Zhou L et al (2024).
- Phytomedicine.
- PubMed:
- 38394737